Artifactless superelastic alloy
    1.
    发明授权

    公开(公告)号:US11268168B2

    公开(公告)日:2022-03-08

    申请号:US16641146

    申请日:2018-08-09

    摘要: The present invention provides an artifactless superelastic alloy including a Au—Cu—Al alloy, the superelastic alloy containing Cu in an amount of 20 atom % or more and 40 atom % or less, Al in an amount of 15 atom % or more and 25 atom % or less, and Au as a balance, the superelastic alloy having a bulk magnetic susceptibility of −24 ppm or more and 6 ppm or less. The Ni-free superelastic alloy of the present invention is capable of exhibiting superelasticity in a normal temperature range, and hardly generated artifacts in a magnetic field environment. The alloy can be produced by setting a casting time in a melting and casting step to a fixed time, and hot-pressing an alloy after casting to make material structures homogeneous.

    Pt—Co based alloy for medical use

    公开(公告)号:US11795527B2

    公开(公告)日:2023-10-24

    申请号:US17295778

    申请日:2019-11-18

    IPC分类号: C22C19/07 A61L31/02

    CPC分类号: C22C19/07 A61L31/022

    摘要: The present invention relates to an alloy for medical use, including Pt, Co, Cr, Ni, and Mo. The alloy includes 10 atom % or more and 30 atom % or less of Pt, 20 atom % or more and 31 atom % or less of Cr, 5 atom % or more and 24 atom % or less of Ni, 4 atom % or more and 8 atom % or less of Mo, the balance Co, and unavoidable impurities, and a ratio of the Ni content (CNi) to the Pt content (CPt), CNi/CPt is 1.5 or less. The present invention can be applied to various kinds of devices for medical use, such as catheter, embolic coils, and guide wires, in addition to stents such as flow-diverter stents.

    Production method for dodecacarbonyl triruthenium
    6.
    发明授权
    Production method for dodecacarbonyl triruthenium 有权
    十二羰基三钌的制备方法

    公开(公告)号:US09266916B2

    公开(公告)日:2016-02-23

    申请号:US14655076

    申请日:2014-01-20

    IPC分类号: C07F15/00

    摘要: The present invention is a method for producing dodecacarbonyl triruthenium (DCR) including a process of carbonylating ruthenium chloride with carbon monoxide, in which an amine is added to a reaction system at 0.8 molar equivalent or more with respect to chlorine of the ruthenium chloride and the carbonylation is conducted at a reaction temperature of 50 to 100° C. and a reaction pressure of 0.2 to 0.9 MPa. According to the present invention, it is possible to produce dodecacarbonyl triruthenium having less residual impurity metals without applying a reaction condition of a high pressure.

    摘要翻译: 本发明是一种生产十二羰基三钌(DCR)的方法,其包括使用一氧化碳羰基化氯化钌的方法,其中胺相对于氯化钌的氯为0.8摩尔当量以上而添加到反应体系中, 在50〜100℃的反应温度和0.2〜0.9MPa的反应压力下进行羰基化。 根据本发明,可以在不施加高压反应条件的情况下制造具有较少残留杂质金属的十二羰基三钌。

    Alloy for medical use, and method for producing same

    公开(公告)号:US11345986B2

    公开(公告)日:2022-05-31

    申请号:US17077344

    申请日:2020-10-22

    IPC分类号: C22F1/14 C22C5/02

    摘要: The present invention provides an alloy for medical use including an Au—Pt alloy, in which the Au—Pt alloy has a Pt concentration of 24 mass % or more and less than 34 mass % with the balance being Au, and has at least a material structure in which a Pt-rich phase having a Pt concentration higher than that of an α-phase is distributed in an α-phase matrix, the Pt-rich phase has a Pt concentration that is 1.2 to 3.8 times the Pt concentration of the α-phase, and the Pt-rich phase has an area ratio of 1 to 22% in any cross-section. This alloy is an artifact-free alloy material that exhibits excellent compatibility with a magnetic field environment such as an MRI and has magnetic susceptibility of ±4 ppm with respect to magnetic susceptibility of water.

    Medical Au-Pt-Pd alloy
    9.
    发明授权

    公开(公告)号:US11453931B2

    公开(公告)日:2022-09-27

    申请号:US17607397

    申请日:2020-09-24

    IPC分类号: C22C5/02 C22C1/02

    摘要: The present invention relates to a medical Au—Pt—Pd alloy including Au, Pt, Pd, and inevitable impurities. The alloy has an alloy composition inside a polygon (A1-A2-A3-A4-A5-A6) surrounded by straight lines connected at point A1 (Au: 37.9 atom %, Pt: 0.1 atom %, and Pd: 62 atom %), point A2 (Au: 79.9 atom %, Pt: 0.1 atom %, and Pd: 20 atom %), point A3 (Au: 79.9 atom %, Pt: 20 atom %, and Pd: 0.1 atom %), point A4 (Au: 69.9 atom %, Pt: 30 atom %, and Pd: 0.1 atom %), point A5 (Au: 49 atom %, Pt: 30 atom %, and Pd: 21 atom %), and point A6 (Au: 39 atom %, Pt: 40 atom %, and Pd: 21 atom %) in a Au—Pt—Pd ternary state diagram. The metal structure of the alloy is optimized, and the metal structure is close to a single-phase structure, and has little precipitation of a Au-rich phase and a Pt-rich phase different in composition from a mother phase.

    Alloy for medical use, and method for producing same

    公开(公告)号:US10883162B2

    公开(公告)日:2021-01-05

    申请号:US15106508

    申请日:2014-01-30

    IPC分类号: C22C5/02 C22C5/04 C22F1/14

    摘要: The present invention provides an alloy for medical use including an Au—Pt alloy, in which the Au—Pt alloy has a Pt concentration of 24 mass % or more and less than 34 mass % with the balance being Au, and has at least a material structure in which a Pt-rich phase having a Pt concentration higher than that of an α-phase is distributed in an α-phase matrix, the Pt-rich phase has a Pt concentration that is 1.2 to 3.8 times the Pt concentration of the α-phase, and the Pt-rich phase has an area ratio of 1 to 22% in any cross-section. This alloy is an artifact-free alloy material that exhibits excellent compatibility with a magnetic field environment such as an MRI and has magnetic susceptibility of ±4 ppm with respect to magnetic susceptibility of water.